nodes	percent_of_prediction	percent_of_DWPC	metapath
Procarbazine—CYP1B1—Progesterone—uterine cancer	0.292	0.39	CbGbCtD
Procarbazine—XDH—Carboplatin—uterine cancer	0.235	0.313	CbGbCtD
Procarbazine—XDH—Doxorubicin—uterine cancer	0.134	0.179	CbGbCtD
Procarbazine—CYP1B1—Doxorubicin—uterine cancer	0.0893	0.119	CbGbCtD
Procarbazine—XDH—uterine cervix—uterine cancer	0.00301	0.127	CbGeAlD
Procarbazine—CYP1B1—Benzo(a)pyrene metabolism—AKR1C1—uterine cancer	0.00294	0.112	CbGpPWpGaD
Procarbazine—XDH—renal system—uterine cancer	0.00282	0.119	CbGeAlD
Procarbazine—XDH—endometrium—uterine cancer	0.00273	0.115	CbGeAlD
Procarbazine—XDH—mammalian vulva—uterine cancer	0.00264	0.111	CbGeAlD
Procarbazine—CYP1B1—Benzo(a)pyrene metabolism—AKR1C3—uterine cancer	0.00227	0.0865	CbGpPWpGaD
Procarbazine—XDH—female reproductive system—uterine cancer	0.00226	0.0955	CbGeAlD
Procarbazine—XDH—vagina—uterine cancer	0.00204	0.0863	CbGeAlD
Procarbazine—XDH—Oxidative Stress—NFE2L2—uterine cancer	0.00193	0.0737	CbGpPWpGaD
Procarbazine—XDH—Oxidative Stress—GPX3—uterine cancer	0.00184	0.0703	CbGpPWpGaD
Procarbazine—Ibuprofen—CXCL8—uterine cancer	0.00149	1	CrCbGaD
Procarbazine—CYP1B1—smooth muscle tissue—uterine cancer	0.00142	0.0602	CbGeAlD
Procarbazine—CYP1B1—decidua—uterine cancer	0.0014	0.059	CbGeAlD
Procarbazine—CYP1B1—renal system—uterine cancer	0.00137	0.058	CbGeAlD
Procarbazine—CYP1B1—uterus—uterine cancer	0.00122	0.0516	CbGeAlD
Procarbazine—CYP1B1—Endogenous sterols—CYP11A1—uterine cancer	0.00113	0.0433	CbGpPWpGaD
Procarbazine—CYP1B1—female reproductive system—uterine cancer	0.0011	0.0464	CbGeAlD
Procarbazine—CYP1B1—female gonad—uterine cancer	0.000999	0.0422	CbGeAlD
Procarbazine—CYP1B1—Estrogen Receptor Pathway—ESR1—uterine cancer	0.000879	0.0336	CbGpPWpGaD
Procarbazine—XDH—Nucleotide metabolism—RRM2—uterine cancer	0.000871	0.0332	CbGpPWpGaD
Procarbazine—CYP1B1—Endogenous sterols—CYP19A1—uterine cancer	0.000834	0.0318	CbGpPWpGaD
Procarbazine—XDH—Selenium Micronutrient Network—GPX3—uterine cancer	0.000779	0.0297	CbGpPWpGaD
Procarbazine—CYP1B1—Aryl Hydrocarbon Receptor—NFE2L2—uterine cancer	0.000735	0.028	CbGpPWpGaD
Procarbazine—CYP1B1—Aryl Hydrocarbon Receptor Pathway—NFE2L2—uterine cancer	0.000735	0.028	CbGpPWpGaD
Procarbazine—CYP1B1—lymph node—uterine cancer	0.000642	0.0272	CbGeAlD
Procarbazine—CYP1B1—Arachidonic acid metabolism—AKR1C3—uterine cancer	0.000575	0.0219	CbGpPWpGaD
Procarbazine—CYP1B1—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	0.000526	0.0201	CbGpPWpGaD
Procarbazine—CYP1B1—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	0.000519	0.0198	CbGpPWpGaD
Procarbazine—CYP1B1—Tryptophan metabolism—CYP19A1—uterine cancer	0.000479	0.0183	CbGpPWpGaD
Procarbazine—CYP1B1—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	0.000426	0.0163	CbGpPWpGaD
Procarbazine—CYP1B1—Metapathway biotransformation—AKR1B10—uterine cancer	0.000402	0.0153	CbGpPWpGaD
Procarbazine—XDH—Selenium Micronutrient Network—MTHFR—uterine cancer	0.0004	0.0153	CbGpPWpGaD
Procarbazine—CYP1B1—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	0.000387	0.0148	CbGpPWpGaD
Procarbazine—CYP1B1—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	0.000382	0.0146	CbGpPWpGaD
Procarbazine—CYP1B1—Metapathway biotransformation—AKR1B1—uterine cancer	0.000373	0.0143	CbGpPWpGaD
Procarbazine—CYP1B1—Aryl Hydrocarbon Receptor—ESR1—uterine cancer	0.00032	0.0122	CbGpPWpGaD
Procarbazine—Pneumonia—Etoposide—uterine cancer	0.000319	0.00161	CcSEcCtD
Procarbazine—Somnolence—Medroxyprogesterone Acetate—uterine cancer	0.000318	0.00161	CcSEcCtD
Procarbazine—Nocturia—Doxorubicin—uterine cancer	0.000317	0.0016	CcSEcCtD
Procarbazine—Anaemia—Dactinomycin—uterine cancer	0.000316	0.0016	CcSEcCtD
Procarbazine—Urticaria—Progesterone—uterine cancer	0.000314	0.00158	CcSEcCtD
Procarbazine—CYP1B1—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	0.000314	0.012	CbGpPWpGaD
Procarbazine—XDH—Selenium Micronutrient Network—CCL2—uterine cancer	0.000313	0.0119	CbGpPWpGaD
Procarbazine—Abdominal pain—Progesterone—uterine cancer	0.000312	0.00158	CcSEcCtD
Procarbazine—Body temperature increased—Progesterone—uterine cancer	0.000312	0.00158	CcSEcCtD
Procarbazine—Decreased appetite—Medroxyprogesterone Acetate—uterine cancer	0.000311	0.00157	CcSEcCtD
Procarbazine—Dysarthria—Doxorubicin—uterine cancer	0.000311	0.00157	CcSEcCtD
Procarbazine—Neuropathy peripheral—Etoposide—uterine cancer	0.000311	0.00157	CcSEcCtD
Procarbazine—Melaena—Epirubicin—uterine cancer	0.00031	0.00157	CcSEcCtD
Procarbazine—Jaundice—Etoposide—uterine cancer	0.000309	0.00156	CcSEcCtD
Procarbazine—Stomatitis—Etoposide—uterine cancer	0.000309	0.00156	CcSEcCtD
Procarbazine—Fatigue—Medroxyprogesterone Acetate—uterine cancer	0.000309	0.00156	CcSEcCtD
Procarbazine—Leukopenia—Dactinomycin—uterine cancer	0.000306	0.00155	CcSEcCtD
Procarbazine—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.000306	0.00155	CcSEcCtD
Procarbazine—Neuropathy—Epirubicin—uterine cancer	0.000298	0.0015	CcSEcCtD
Procarbazine—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.000295	0.00149	CcSEcCtD
Procarbazine—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.000293	0.00148	CcSEcCtD
Procarbazine—Myalgia—Dactinomycin—uterine cancer	0.000291	0.00147	CcSEcCtD
Procarbazine—Hypersensitivity—Progesterone—uterine cancer	0.000291	0.00147	CcSEcCtD
Procarbazine—Coma—Epirubicin—uterine cancer	0.00029	0.00146	CcSEcCtD
Procarbazine—Melaena—Doxorubicin—uterine cancer	0.000287	0.00145	CcSEcCtD
Procarbazine—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.000284	0.00144	CcSEcCtD
Procarbazine—Asthenia—Progesterone—uterine cancer	0.000284	0.00143	CcSEcCtD
Procarbazine—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.000283	0.00143	CcSEcCtD
Procarbazine—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.000283	0.00143	CcSEcCtD
Procarbazine—Pruritus—Progesterone—uterine cancer	0.00028	0.00141	CcSEcCtD
Procarbazine—Oedema—Dactinomycin—uterine cancer	0.000279	0.00141	CcSEcCtD
Procarbazine—Infection—Dactinomycin—uterine cancer	0.000277	0.0014	CcSEcCtD
Procarbazine—Neuropathy—Doxorubicin—uterine cancer	0.000276	0.00139	CcSEcCtD
Procarbazine—CYP1B1—Metapathway biotransformation—AKR1C1—uterine cancer	0.000274	0.0105	CbGpPWpGaD
Procarbazine—Thrombocytopenia—Dactinomycin—uterine cancer	0.000273	0.00138	CcSEcCtD
Procarbazine—Diarrhoea—Progesterone—uterine cancer	0.00027	0.00136	CcSEcCtD
Procarbazine—Coma—Doxorubicin—uterine cancer	0.000269	0.00136	CcSEcCtD
Procarbazine—Anorexia—Dactinomycin—uterine cancer	0.000266	0.00134	CcSEcCtD
Procarbazine—Flushing—Etoposide—uterine cancer	0.000264	0.00133	CcSEcCtD
Procarbazine—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.000264	0.00133	CcSEcCtD
Procarbazine—Hepatic function abnormal—Epirubicin—uterine cancer	0.000264	0.00133	CcSEcCtD
Procarbazine—Photosensitivity—Epirubicin—uterine cancer	0.000263	0.00132	CcSEcCtD
Procarbazine—Dizziness—Progesterone—uterine cancer	0.000261	0.00132	CcSEcCtD
Procarbazine—Vascular purpura—Epirubicin—uterine cancer	0.000258	0.0013	CcSEcCtD
Procarbazine—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.000257	0.0013	CcSEcCtD
Procarbazine—Chills—Etoposide—uterine cancer	0.000255	0.00129	CcSEcCtD
Procarbazine—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.000254	0.00128	CcSEcCtD
Procarbazine—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.000253	0.00128	CcSEcCtD
Procarbazine—Alopecia—Etoposide—uterine cancer	0.000251	0.00127	CcSEcCtD
Procarbazine—Vomiting—Progesterone—uterine cancer	0.000251	0.00127	CcSEcCtD
Procarbazine—Rash—Progesterone—uterine cancer	0.000249	0.00126	CcSEcCtD
Procarbazine—Dermatitis—Progesterone—uterine cancer	0.000249	0.00126	CcSEcCtD
Procarbazine—Headache—Progesterone—uterine cancer	0.000248	0.00125	CcSEcCtD
Procarbazine—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000245	0.00124	CcSEcCtD
Procarbazine—Hepatic function abnormal—Doxorubicin—uterine cancer	0.000244	0.00123	CcSEcCtD
Procarbazine—Photosensitivity—Doxorubicin—uterine cancer	0.000243	0.00123	CcSEcCtD
Procarbazine—Decreased appetite—Dactinomycin—uterine cancer	0.000243	0.00123	CcSEcCtD
Procarbazine—Fatigue—Dactinomycin—uterine cancer	0.000241	0.00122	CcSEcCtD
Procarbazine—CYP1B1—Metapathway biotransformation—GPX3—uterine cancer	0.000241	0.00919	CbGpPWpGaD
Procarbazine—Purpura—Epirubicin—uterine cancer	0.000239	0.00121	CcSEcCtD
Procarbazine—Pain—Dactinomycin—uterine cancer	0.000239	0.00121	CcSEcCtD
Procarbazine—Vascular purpura—Doxorubicin—uterine cancer	0.000238	0.0012	CcSEcCtD
Procarbazine—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000237	0.00119	CcSEcCtD
Procarbazine—Lethargy—Epirubicin—uterine cancer	0.000235	0.00119	CcSEcCtD
Procarbazine—Nausea—Progesterone—uterine cancer	0.000235	0.00118	CcSEcCtD
Procarbazine—Diplopia—Epirubicin—uterine cancer	0.000231	0.00116	CcSEcCtD
Procarbazine—Feeling abnormal—Dactinomycin—uterine cancer	0.00023	0.00116	CcSEcCtD
Procarbazine—Anaemia—Etoposide—uterine cancer	0.000229	0.00116	CcSEcCtD
Procarbazine—Gastrointestinal pain—Dactinomycin—uterine cancer	0.000228	0.00115	CcSEcCtD
Procarbazine—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000228	0.00115	CcSEcCtD
Procarbazine—CYP1B1—Biological oxidations—CYP11A1—uterine cancer	0.000227	0.00865	CbGpPWpGaD
Procarbazine—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000226	0.00114	CcSEcCtD
Procarbazine—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000226	0.00114	CcSEcCtD
Procarbazine—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000224	0.00113	CcSEcCtD
Procarbazine—CYP1B1—Metapathway biotransformation—CYP11A1—uterine cancer	0.000223	0.00853	CbGpPWpGaD
Procarbazine—Leukopenia—Etoposide—uterine cancer	0.000222	0.00112	CcSEcCtD
Procarbazine—Purpura—Doxorubicin—uterine cancer	0.000221	0.00112	CcSEcCtD
Procarbazine—Body temperature increased—Dactinomycin—uterine cancer	0.000221	0.00111	CcSEcCtD
Procarbazine—Abdominal pain—Dactinomycin—uterine cancer	0.000221	0.00111	CcSEcCtD
Procarbazine—Loss of consciousness—Etoposide—uterine cancer	0.000218	0.0011	CcSEcCtD
Procarbazine—Lethargy—Doxorubicin—uterine cancer	0.000218	0.0011	CcSEcCtD
Procarbazine—CYP1B1—Aryl Hydrocarbon Receptor Pathway—CDKN1B—uterine cancer	0.000217	0.0083	CbGpPWpGaD
Procarbazine—CYP1B1—Aryl Hydrocarbon Receptor—CDKN1B—uterine cancer	0.000217	0.0083	CbGpPWpGaD
Procarbazine—Ataxia—Epirubicin—uterine cancer	0.000217	0.00109	CcSEcCtD
Procarbazine—Cough—Etoposide—uterine cancer	0.000216	0.00109	CcSEcCtD
Procarbazine—Convulsion—Etoposide—uterine cancer	0.000215	0.00108	CcSEcCtD
Procarbazine—Hypertension—Etoposide—uterine cancer	0.000214	0.00108	CcSEcCtD
Procarbazine—Diplopia—Doxorubicin—uterine cancer	0.000213	0.00108	CcSEcCtD
Procarbazine—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000213	0.00107	CcSEcCtD
Procarbazine—CYP1B1—Metapathway biotransformation—AKR1C3—uterine cancer	0.000211	0.00806	CbGpPWpGaD
Procarbazine—Toxic epidermal necrolysis—Epirubicin—uterine cancer	0.000208	0.00105	CcSEcCtD
Procarbazine—Hypersensitivity—Dactinomycin—uterine cancer	0.000206	0.00104	CcSEcCtD
Procarbazine—Confusional state—Etoposide—uterine cancer	0.000204	0.00103	CcSEcCtD
Procarbazine—CYP1B1—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	0.000201	0.00768	CbGpPWpGaD
Procarbazine—Infection—Etoposide—uterine cancer	0.000201	0.00101	CcSEcCtD
Procarbazine—Ataxia—Doxorubicin—uterine cancer	0.000201	0.00101	CcSEcCtD
Procarbazine—Asthenia—Dactinomycin—uterine cancer	0.0002	0.00101	CcSEcCtD
Procarbazine—Dysphagia—Epirubicin—uterine cancer	0.000199	0.00101	CcSEcCtD
Procarbazine—Thrombocytopenia—Etoposide—uterine cancer	0.000198	0.000999	CcSEcCtD
Procarbazine—Tachycardia—Etoposide—uterine cancer	0.000197	0.000996	CcSEcCtD
Procarbazine—Eosinophilia—Epirubicin—uterine cancer	0.000197	0.000996	CcSEcCtD
Procarbazine—Hyperhidrosis—Etoposide—uterine cancer	0.000195	0.000986	CcSEcCtD
Procarbazine—Pancreatitis—Epirubicin—uterine cancer	0.000195	0.000986	CcSEcCtD
Procarbazine—Angina pectoris—Epirubicin—uterine cancer	0.000194	0.00098	CcSEcCtD
Procarbazine—Anorexia—Etoposide—uterine cancer	0.000193	0.000972	CcSEcCtD
Procarbazine—Toxic epidermal necrolysis—Doxorubicin—uterine cancer	0.000192	0.000969	CcSEcCtD
Procarbazine—Diarrhoea—Dactinomycin—uterine cancer	0.000191	0.000964	CcSEcCtD
Procarbazine—CYP1B1—Aryl Hydrocarbon Receptor—EP300—uterine cancer	0.000191	0.00729	CbGpPWpGaD
Procarbazine—CYP1B1—Aryl Hydrocarbon Receptor Pathway—EP300—uterine cancer	0.000191	0.00729	CbGpPWpGaD
Procarbazine—Pancytopenia—Epirubicin—uterine cancer	0.000189	0.000955	CcSEcCtD
Procarbazine—Hypotension—Etoposide—uterine cancer	0.000189	0.000953	CcSEcCtD
Procarbazine—Dysphagia—Doxorubicin—uterine cancer	0.000184	0.00093	CcSEcCtD
Procarbazine—Pollakiuria—Epirubicin—uterine cancer	0.000184	0.000929	CcSEcCtD
Procarbazine—Eosinophilia—Doxorubicin—uterine cancer	0.000183	0.000921	CcSEcCtD
Procarbazine—Photosensitivity reaction—Epirubicin—uterine cancer	0.000182	0.000918	CcSEcCtD
Procarbazine—Paraesthesia—Etoposide—uterine cancer	0.000182	0.000916	CcSEcCtD
Procarbazine—Pancreatitis—Doxorubicin—uterine cancer	0.000181	0.000912	CcSEcCtD
Procarbazine—CYP1B1—Aryl Hydrocarbon Receptor—VEGFA—uterine cancer	0.000181	0.0069	CbGpPWpGaD
Procarbazine—Somnolence—Etoposide—uterine cancer	0.00018	0.000907	CcSEcCtD
Procarbazine—Angina pectoris—Doxorubicin—uterine cancer	0.00018	0.000906	CcSEcCtD
Procarbazine—Pneumonia—Epirubicin—uterine cancer	0.000179	0.000902	CcSEcCtD
Procarbazine—CYP1B1—Aryl Hydrocarbon Receptor—NRAS—uterine cancer	0.000179	0.00682	CbGpPWpGaD
Procarbazine—Drowsiness—Epirubicin—uterine cancer	0.000178	0.000897	CcSEcCtD
Procarbazine—Vomiting—Dactinomycin—uterine cancer	0.000178	0.000896	CcSEcCtD
Procarbazine—Rash—Dactinomycin—uterine cancer	0.000176	0.000889	CcSEcCtD
Procarbazine—Decreased appetite—Etoposide—uterine cancer	0.000176	0.000887	CcSEcCtD
Procarbazine—Pancytopenia—Doxorubicin—uterine cancer	0.000175	0.000884	CcSEcCtD
Procarbazine—Fatigue—Etoposide—uterine cancer	0.000174	0.000879	CcSEcCtD
Procarbazine—Neuropathy peripheral—Epirubicin—uterine cancer	0.000174	0.000879	CcSEcCtD
Procarbazine—Stomatitis—Epirubicin—uterine cancer	0.000173	0.000874	CcSEcCtD
Procarbazine—Jaundice—Epirubicin—uterine cancer	0.000173	0.000874	CcSEcCtD
Procarbazine—Constipation—Etoposide—uterine cancer	0.000173	0.000872	CcSEcCtD
Procarbazine—Pain—Etoposide—uterine cancer	0.000173	0.000872	CcSEcCtD
Procarbazine—Sweating—Epirubicin—uterine cancer	0.00017	0.00086	CcSEcCtD
Procarbazine—Pollakiuria—Doxorubicin—uterine cancer	0.00017	0.000859	CcSEcCtD
Procarbazine—Haematuria—Epirubicin—uterine cancer	0.000169	0.000855	CcSEcCtD
Procarbazine—Photosensitivity reaction—Doxorubicin—uterine cancer	0.000168	0.000849	CcSEcCtD
Procarbazine—Epistaxis—Epirubicin—uterine cancer	0.000168	0.000846	CcSEcCtD
Procarbazine—XDH—Metabolism—NDUFB11—uterine cancer	0.000167	0.00638	CbGpPWpGaD
Procarbazine—XDH—Metabolism—SRD5A2—uterine cancer	0.000167	0.00638	CbGpPWpGaD
Procarbazine—CYP1B1—Biological oxidations—CYP19A1—uterine cancer	0.000167	0.00636	CbGpPWpGaD
Procarbazine—Feeling abnormal—Etoposide—uterine cancer	0.000167	0.000841	CcSEcCtD
Procarbazine—Nausea—Dactinomycin—uterine cancer	0.000166	0.000837	CcSEcCtD
Procarbazine—Pneumonia—Doxorubicin—uterine cancer	0.000165	0.000834	CcSEcCtD
Procarbazine—Gastrointestinal pain—Etoposide—uterine cancer	0.000165	0.000834	CcSEcCtD
Procarbazine—Drowsiness—Doxorubicin—uterine cancer	0.000164	0.00083	CcSEcCtD
Procarbazine—CYP1B1—Metapathway biotransformation—CYP19A1—uterine cancer	0.000164	0.00628	CbGpPWpGaD
Procarbazine—Neuropathy peripheral—Doxorubicin—uterine cancer	0.000161	0.000813	CcSEcCtD
Procarbazine—Urticaria—Etoposide—uterine cancer	0.000161	0.00081	CcSEcCtD
Procarbazine—Haemoglobin—Epirubicin—uterine cancer	0.00016	0.000809	CcSEcCtD
Procarbazine—Jaundice—Doxorubicin—uterine cancer	0.00016	0.000809	CcSEcCtD
Procarbazine—Stomatitis—Doxorubicin—uterine cancer	0.00016	0.000809	CcSEcCtD
Procarbazine—Abdominal pain—Etoposide—uterine cancer	0.00016	0.000806	CcSEcCtD
Procarbazine—Body temperature increased—Etoposide—uterine cancer	0.00016	0.000806	CcSEcCtD
Procarbazine—Haemorrhage—Epirubicin—uterine cancer	0.000159	0.000805	CcSEcCtD
Procarbazine—Sweating—Doxorubicin—uterine cancer	0.000158	0.000795	CcSEcCtD
Procarbazine—Haematuria—Doxorubicin—uterine cancer	0.000157	0.000791	CcSEcCtD
Procarbazine—Epistaxis—Doxorubicin—uterine cancer	0.000155	0.000782	CcSEcCtD
Procarbazine—CYP1B1—Aryl Hydrocarbon Receptor—KRAS—uterine cancer	0.000154	0.00587	CbGpPWpGaD
Procarbazine—Hypersensitivity—Etoposide—uterine cancer	0.000149	0.000752	CcSEcCtD
Procarbazine—Haemoglobin—Doxorubicin—uterine cancer	0.000148	0.000748	CcSEcCtD
Procarbazine—Flushing—Epirubicin—uterine cancer	0.000148	0.000747	CcSEcCtD
Procarbazine—Haemorrhage—Doxorubicin—uterine cancer	0.000148	0.000745	CcSEcCtD
Procarbazine—CYP1B1—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	0.000145	0.00555	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism of lipids and lipoproteins—STAR—uterine cancer	0.000145	0.00555	CbGpPWpGaD
Procarbazine—Asthenia—Etoposide—uterine cancer	0.000145	0.000732	CcSEcCtD
Procarbazine—Chills—Epirubicin—uterine cancer	0.000143	0.000722	CcSEcCtD
Procarbazine—Pruritus—Etoposide—uterine cancer	0.000143	0.000722	CcSEcCtD
Procarbazine—Arrhythmia—Epirubicin—uterine cancer	0.000142	0.000719	CcSEcCtD
Procarbazine—Alopecia—Epirubicin—uterine cancer	0.000141	0.000711	CcSEcCtD
Procarbazine—Diarrhoea—Etoposide—uterine cancer	0.000138	0.000698	CcSEcCtD
Procarbazine—Flushing—Doxorubicin—uterine cancer	0.000137	0.000691	CcSEcCtD
Procarbazine—Tension—Epirubicin—uterine cancer	0.000136	0.000688	CcSEcCtD
Procarbazine—Nervousness—Epirubicin—uterine cancer	0.000135	0.00068	CcSEcCtD
Procarbazine—Dizziness—Etoposide—uterine cancer	0.000134	0.000675	CcSEcCtD
Procarbazine—Chills—Doxorubicin—uterine cancer	0.000132	0.000668	CcSEcCtD
Procarbazine—Arrhythmia—Doxorubicin—uterine cancer	0.000132	0.000665	CcSEcCtD
Procarbazine—CYP1B1—Aryl Hydrocarbon Receptor—HRAS—uterine cancer	0.000131	0.00499	CbGpPWpGaD
Procarbazine—Alopecia—Doxorubicin—uterine cancer	0.00013	0.000658	CcSEcCtD
Procarbazine—Vomiting—Etoposide—uterine cancer	0.000129	0.000649	CcSEcCtD
Procarbazine—Anaemia—Epirubicin—uterine cancer	0.000128	0.000648	CcSEcCtD
Procarbazine—Rash—Etoposide—uterine cancer	0.000127	0.000643	CcSEcCtD
Procarbazine—Dermatitis—Etoposide—uterine cancer	0.000127	0.000643	CcSEcCtD
Procarbazine—Headache—Etoposide—uterine cancer	0.000127	0.000639	CcSEcCtD
Procarbazine—Tension—Doxorubicin—uterine cancer	0.000126	0.000636	CcSEcCtD
Procarbazine—Nervousness—Doxorubicin—uterine cancer	0.000125	0.00063	CcSEcCtD
Procarbazine—Syncope—Epirubicin—uterine cancer	0.000125	0.000628	CcSEcCtD
Procarbazine—Leukopenia—Epirubicin—uterine cancer	0.000124	0.000627	CcSEcCtD
Procarbazine—Loss of consciousness—Epirubicin—uterine cancer	0.000122	0.000616	CcSEcCtD
Procarbazine—Cough—Epirubicin—uterine cancer	0.000121	0.000611	CcSEcCtD
Procarbazine—XDH—Metabolism—AKR1B1—uterine cancer	0.000121	0.00462	CbGpPWpGaD
Procarbazine—XDH—Metabolism—STAR—uterine cancer	0.000121	0.00462	CbGpPWpGaD
Procarbazine—Convulsion—Epirubicin—uterine cancer	0.00012	0.000607	CcSEcCtD
Procarbazine—Nausea—Etoposide—uterine cancer	0.00012	0.000606	CcSEcCtD
Procarbazine—Hypertension—Epirubicin—uterine cancer	0.00012	0.000605	CcSEcCtD
Procarbazine—Anaemia—Doxorubicin—uterine cancer	0.000119	0.000599	CcSEcCtD
Procarbazine—Myalgia—Epirubicin—uterine cancer	0.000118	0.000596	CcSEcCtD
Procarbazine—Arthralgia—Epirubicin—uterine cancer	0.000118	0.000596	CcSEcCtD
Procarbazine—Anxiety—Epirubicin—uterine cancer	0.000118	0.000594	CcSEcCtD
Procarbazine—Dry mouth—Epirubicin—uterine cancer	0.000116	0.000583	CcSEcCtD
Procarbazine—Syncope—Doxorubicin—uterine cancer	0.000115	0.000581	CcSEcCtD
Procarbazine—Leukopenia—Doxorubicin—uterine cancer	0.000115	0.00058	CcSEcCtD
Procarbazine—Confusional state—Epirubicin—uterine cancer	0.000114	0.000577	CcSEcCtD
Procarbazine—Oedema—Epirubicin—uterine cancer	0.000113	0.000572	CcSEcCtD
Procarbazine—Loss of consciousness—Doxorubicin—uterine cancer	0.000113	0.00057	CcSEcCtD
Procarbazine—Infection—Epirubicin—uterine cancer	0.000113	0.000568	CcSEcCtD
Procarbazine—Cough—Doxorubicin—uterine cancer	0.000112	0.000566	CcSEcCtD
Procarbazine—Shock—Epirubicin—uterine cancer	0.000111	0.000563	CcSEcCtD
Procarbazine—Convulsion—Doxorubicin—uterine cancer	0.000111	0.000562	CcSEcCtD
Procarbazine—Thrombocytopenia—Epirubicin—uterine cancer	0.000111	0.00056	CcSEcCtD
Procarbazine—Hypertension—Doxorubicin—uterine cancer	0.000111	0.00056	CcSEcCtD
Procarbazine—Tachycardia—Epirubicin—uterine cancer	0.000111	0.000558	CcSEcCtD
Procarbazine—Hyperhidrosis—Epirubicin—uterine cancer	0.00011	0.000553	CcSEcCtD
Procarbazine—Arthralgia—Doxorubicin—uterine cancer	0.000109	0.000552	CcSEcCtD
Procarbazine—Myalgia—Doxorubicin—uterine cancer	0.000109	0.000552	CcSEcCtD
Procarbazine—Anxiety—Doxorubicin—uterine cancer	0.000109	0.00055	CcSEcCtD
Procarbazine—Anorexia—Epirubicin—uterine cancer	0.000108	0.000545	CcSEcCtD
Procarbazine—Dry mouth—Doxorubicin—uterine cancer	0.000107	0.00054	CcSEcCtD
Procarbazine—CYP1B1—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	0.000107	0.00407	CbGpPWpGaD
Procarbazine—Hypotension—Epirubicin—uterine cancer	0.000106	0.000534	CcSEcCtD
Procarbazine—Confusional state—Doxorubicin—uterine cancer	0.000106	0.000533	CcSEcCtD
Procarbazine—Oedema—Doxorubicin—uterine cancer	0.000105	0.000529	CcSEcCtD
Procarbazine—Infection—Doxorubicin—uterine cancer	0.000104	0.000526	CcSEcCtD
Procarbazine—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000103	0.000521	CcSEcCtD
Procarbazine—Shock—Doxorubicin—uterine cancer	0.000103	0.000521	CcSEcCtD
Procarbazine—Thrombocytopenia—Doxorubicin—uterine cancer	0.000103	0.000518	CcSEcCtD
Procarbazine—Insomnia—Epirubicin—uterine cancer	0.000102	0.000517	CcSEcCtD
Procarbazine—Tachycardia—Doxorubicin—uterine cancer	0.000102	0.000516	CcSEcCtD
Procarbazine—Paraesthesia—Epirubicin—uterine cancer	0.000102	0.000513	CcSEcCtD
Procarbazine—Hyperhidrosis—Doxorubicin—uterine cancer	0.000101	0.000511	CcSEcCtD
Procarbazine—Somnolence—Epirubicin—uterine cancer	0.000101	0.000508	CcSEcCtD
Procarbazine—Anorexia—Doxorubicin—uterine cancer	9.99e-05	0.000504	CcSEcCtD
Procarbazine—Decreased appetite—Epirubicin—uterine cancer	9.85e-05	0.000497	CcSEcCtD
Procarbazine—Hypotension—Doxorubicin—uterine cancer	9.8e-05	0.000494	CcSEcCtD
Procarbazine—Fatigue—Epirubicin—uterine cancer	9.77e-05	0.000493	CcSEcCtD
Procarbazine—Constipation—Epirubicin—uterine cancer	9.69e-05	0.000489	CcSEcCtD
Procarbazine—Pain—Epirubicin—uterine cancer	9.69e-05	0.000489	CcSEcCtD
Procarbazine—Musculoskeletal discomfort—Doxorubicin—uterine cancer	9.55e-05	0.000482	CcSEcCtD
Procarbazine—XDH—Metabolism—POLD1—uterine cancer	9.49e-05	0.00362	CbGpPWpGaD
Procarbazine—Insomnia—Doxorubicin—uterine cancer	9.48e-05	0.000479	CcSEcCtD
Procarbazine—Paraesthesia—Doxorubicin—uterine cancer	9.41e-05	0.000475	CcSEcCtD
Procarbazine—Feeling abnormal—Epirubicin—uterine cancer	9.34e-05	0.000471	CcSEcCtD
Procarbazine—Somnolence—Doxorubicin—uterine cancer	9.32e-05	0.00047	CcSEcCtD
Procarbazine—Gastrointestinal pain—Epirubicin—uterine cancer	9.27e-05	0.000468	CcSEcCtD
Procarbazine—Decreased appetite—Doxorubicin—uterine cancer	9.11e-05	0.00046	CcSEcCtD
Procarbazine—Fatigue—Doxorubicin—uterine cancer	9.04e-05	0.000456	CcSEcCtD
Procarbazine—Urticaria—Epirubicin—uterine cancer	9e-05	0.000454	CcSEcCtD
Procarbazine—Pain—Doxorubicin—uterine cancer	8.97e-05	0.000452	CcSEcCtD
Procarbazine—Constipation—Doxorubicin—uterine cancer	8.97e-05	0.000452	CcSEcCtD
Procarbazine—Abdominal pain—Epirubicin—uterine cancer	8.96e-05	0.000452	CcSEcCtD
Procarbazine—Body temperature increased—Epirubicin—uterine cancer	8.96e-05	0.000452	CcSEcCtD
Procarbazine—CYP1B1—Metabolism—SRD5A2—uterine cancer	8.96e-05	0.00342	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—NDUFB11—uterine cancer	8.96e-05	0.00342	CbGpPWpGaD
Procarbazine—XDH—Metabolism—AKR1C1—uterine cancer	8.87e-05	0.00339	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	8.7e-05	0.00332	CbGpPWpGaD
Procarbazine—Feeling abnormal—Doxorubicin—uterine cancer	8.64e-05	0.000436	CcSEcCtD
Procarbazine—Gastrointestinal pain—Doxorubicin—uterine cancer	8.57e-05	0.000433	CcSEcCtD
Procarbazine—Hypersensitivity—Epirubicin—uterine cancer	8.35e-05	0.000421	CcSEcCtD
Procarbazine—Urticaria—Doxorubicin—uterine cancer	8.33e-05	0.00042	CcSEcCtD
Procarbazine—Abdominal pain—Doxorubicin—uterine cancer	8.29e-05	0.000418	CcSEcCtD
Procarbazine—Body temperature increased—Doxorubicin—uterine cancer	8.29e-05	0.000418	CcSEcCtD
Procarbazine—CYP1B1—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	8.22e-05	0.00314	CbGpPWpGaD
Procarbazine—Asthenia—Epirubicin—uterine cancer	8.13e-05	0.00041	CcSEcCtD
Procarbazine—Pruritus—Epirubicin—uterine cancer	8.02e-05	0.000405	CcSEcCtD
Procarbazine—XDH—Metabolism—RRM2—uterine cancer	7.91e-05	0.00302	CbGpPWpGaD
Procarbazine—Diarrhoea—Epirubicin—uterine cancer	7.75e-05	0.000391	CcSEcCtD
Procarbazine—Hypersensitivity—Doxorubicin—uterine cancer	7.72e-05	0.00039	CcSEcCtD
Procarbazine—XDH—Metabolism—DCN—uterine cancer	7.68e-05	0.00293	CbGpPWpGaD
Procarbazine—Asthenia—Doxorubicin—uterine cancer	7.52e-05	0.00038	CcSEcCtD
Procarbazine—Dizziness—Epirubicin—uterine cancer	7.49e-05	0.000378	CcSEcCtD
Procarbazine—Pruritus—Doxorubicin—uterine cancer	7.42e-05	0.000374	CcSEcCtD
Procarbazine—XDH—Metabolism—CYP11A1—uterine cancer	7.23e-05	0.00276	CbGpPWpGaD
Procarbazine—Vomiting—Epirubicin—uterine cancer	7.2e-05	0.000364	CcSEcCtD
Procarbazine—Diarrhoea—Doxorubicin—uterine cancer	7.17e-05	0.000362	CcSEcCtD
Procarbazine—Rash—Epirubicin—uterine cancer	7.14e-05	0.000361	CcSEcCtD
Procarbazine—Dermatitis—Epirubicin—uterine cancer	7.14e-05	0.00036	CcSEcCtD
Procarbazine—Headache—Epirubicin—uterine cancer	7.1e-05	0.000358	CcSEcCtD
Procarbazine—Dizziness—Doxorubicin—uterine cancer	6.93e-05	0.00035	CcSEcCtD
Procarbazine—XDH—Metabolism—AKR1C3—uterine cancer	6.83e-05	0.00261	CbGpPWpGaD
Procarbazine—Nausea—Epirubicin—uterine cancer	6.73e-05	0.00034	CcSEcCtD
Procarbazine—Vomiting—Doxorubicin—uterine cancer	6.67e-05	0.000336	CcSEcCtD
Procarbazine—Rash—Doxorubicin—uterine cancer	6.61e-05	0.000334	CcSEcCtD
Procarbazine—Dermatitis—Doxorubicin—uterine cancer	6.6e-05	0.000333	CcSEcCtD
Procarbazine—Headache—Doxorubicin—uterine cancer	6.57e-05	0.000331	CcSEcCtD
Procarbazine—CYP1B1—Metabolism—STAR—uterine cancer	6.48e-05	0.00247	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—AKR1B1—uterine cancer	6.48e-05	0.00247	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	6.4e-05	0.00244	CbGpPWpGaD
Procarbazine—Nausea—Doxorubicin—uterine cancer	6.23e-05	0.000314	CcSEcCtD
Procarbazine—XDH—Metabolism—STK11—uterine cancer	5.32e-05	0.00203	CbGpPWpGaD
Procarbazine—XDH—Metabolism—CYP19A1—uterine cancer	5.32e-05	0.00203	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—POLD1—uterine cancer	5.08e-05	0.00194	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—AKR1C1—uterine cancer	4.75e-05	0.00181	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—RRM2—uterine cancer	4.24e-05	0.00162	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—DCN—uterine cancer	4.11e-05	0.00157	CbGpPWpGaD
Procarbazine—XDH—Metabolism—MTHFR—uterine cancer	4e-05	0.00153	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—CYP11A1—uterine cancer	3.87e-05	0.00148	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—AKR1C3—uterine cancer	3.66e-05	0.0014	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—STK11—uterine cancer	2.85e-05	0.00109	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—CYP19A1—uterine cancer	2.85e-05	0.00109	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	2.68e-05	0.00102	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	2.55e-05	0.000974	CbGpPWpGaD
Procarbazine—XDH—Metabolism—PTEN—uterine cancer	2.22e-05	0.000849	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—MTHFR—uterine cancer	2.14e-05	0.000818	CbGpPWpGaD
Procarbazine—XDH—Metabolism—EP300—uterine cancer	2.12e-05	0.00081	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.89e-05	0.000721	CbGpPWpGaD
Procarbazine—XDH—Metabolism—PIK3CA—uterine cancer	1.57e-05	0.000599	CbGpPWpGaD
Procarbazine—XDH—Metabolism—AKT1—uterine cancer	1.28e-05	0.00049	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—PTEN—uterine cancer	1.19e-05	0.000455	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—EP300—uterine cancer	1.14e-05	0.000434	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—PIK3CA—uterine cancer	8.41e-06	0.000321	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—AKT1—uterine cancer	6.87e-06	0.000262	CbGpPWpGaD
